You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
GSK
AstraZeneca
Novo Nordisk
Sanofi
Johnson and Johnson
Eli Lilly
Abbott Labs
Topics

Advertisement

Novartis

Share

Top Latest Popular

In the last 8 hours

New clash between Georgiadis and Salmas over Novartis case: “He is serving reheated conspiracy claims” – “He is adopting Polakis’ allegations” Proto Thema News 20:28 Fri, 24 Jul

Thursday

Novartis India Q1 profit up 16%, revenue climbs 18%; shares fall 3% The Financial Express 09:38 Thu, 23 Jul

Novartis India standalone net profit rises 16.62% in the June 2026 quarter The Business Standard 09:29 Thu, 23 Jul

Advertisement

Advertisement

Wednesday

Car T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight PR Newswire (Press Release) 15:32 Wed, 22 Jul

Novartis CEO Praises Japan And Blasts Germany Over Pricing Scrip Pharma Intelligence 13:06 Wed, 22 Jul

MOHW, Novartis ink 140B won deal to strengthen RLT supply chain Asia Today 02:14 Wed, 22 Jul

Tuesday

Novartis to invest ₩140 bil. in Korea radioligand therapy ecosystem Korea Biomedical Review 22:10 Tue, 21 Jul

Novartis Q2 Earnings & Revenues Top Estimates, Key Drugs Perform Well Zacks 17:45 Tue, 21 Jul

Cosentyx Close To Peak $8bn Sales For Novartis Scrip Pharma Intelligence 16:15 Tue, 21 Jul

Compared to Estimates, Novartis (NVS) Q2 Earnings: A Look at Key Metrics Zacks 15:33 Tue, 21 Jul

Novartis to invest $95 mil. in Korea cancer radiotherapy supply chain The Korea Times 14:38 Tue, 21 Jul

Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline Benzinga 13:26 Tue, 21 Jul

Novartis Q2 profits recover as revenue mantle passes to newer medicines Pharmaceutical Technology 13:06 Tue, 21 Jul

Novartis Stock Gains On Core Operating Income, Volume Growth In Q2; Backs Outlook RTT News 11:45 Tue, 21 Jul

Novartis weathers Entresto slump with return to growth pharmaphorum 11:43 Tue, 21 Jul

Novartis Stock Gains On Core Operting Income, Volume Growth In Q2; Backs Outlook RTT News 11:00 Tue, 21 Jul

Advertisement

Novartis returns to sales growth in second quarter ShareCast 09:48 Tue, 21 Jul

Novartis Q2 profit up as generic competition mounts RTE 08:52 Tue, 21 Jul

Novartis Q2 surpasses estimates despite 50% Entresto sales drop Invezz 08:33 Tue, 21 Jul

Novartis says buoyed by new treatments in second quarter France 24 08:08 Tue, 21 Jul

Novartis posts stronger-than-expected second-quarter results as new cancer drugs boost sales Sweden Herald 06:29 Tue, 21 Jul

Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed Novartis (Press Release) 06:09 Tue, 21 Jul

Novartis verzeichnete im zweiten Quartal Umsatzsteigerungen und baute die Pipeline weiter aus; Prognose für das Geschäftsjahr bekräftigt Novartis (Press Release) 06:09 Tue, 21 Jul

Monday

Novartis and Takeda drugs gain rare blood cancer routine use on NHS Pharmaceutical Technology 14:44 Mon, 20 Jul

In the last month

Can Novartis' Fabhalta Strengthen Its Nephrology Franchise? Zacks 20:31 Fri, 17 Jul

Novartis gains full FDA nod for Fabhalta in kidney disorder IgAN FiercePharma 16:36 Fri, 17 Jul

FDA grants traditional approval to Novartis’ Fabhalta for IgAN Pharmaceutical Technology 11:48 Fri, 17 Jul

Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next Novartis (Press Release) 08:14 Fri, 17 Jul

Novartis Wins FDA Approval For Fabhalta In IgA Nephropathy RTT News 07:04 Fri, 17 Jul

Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN Novartis (Press Release) 01:06 Fri, 17 Jul

AI specialist Chai Discovery raises $400m pharmaphorum 12:48 Wed, 15 Jul

Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight PR Newswire (Press Release) 15:36 Tue, 14 Jul

Novartis and Chai Discovery collaborate on antibody identification Pharmaceutical Business Review 10:40 Tue, 14 Jul

Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery Business Wire (Press Release) 12:00 Mon, 13 Jul

Myricx Bio to be acquired by Novartis Imperial College London 14:16 Fri, 10 Jul

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? The Motley Fool 17:41 Thu, 09 Jul

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight PR Newswire (Press Release) 15:35 Thu, 09 Jul

Novartis acquires Myricx Bio to advance treatment options for cancer patients Pharmaceutical Field 11:14 Thu, 09 Jul

'Every effort must be made' to provide prostate cancer drug to public patients Irish Examiner 01:00 Wed, 08 Jul

Novartis (SWX:NOVN) Is Buying Myricx Bio For Up To $1.5 Billion Simply Wall St 00:59 Wed, 08 Jul

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis